Hybrid imaging for pancreatic malignancy: Clinical applications, merits, limitations, and pitfalls

Priyanka Jha, Bijan Bijan, Giselle M Melendres, David K. Shelton

Research output: Contribution to journalArticle

2 Scopus citations


The role of PET/CT in pancreatic malignancy is evolving with new scientific evidence emerging continuously. PET/CT applications in imaging the pancreas and its organ-specific merits, limitations, and potential pitfalls are still evolving. This article provides an overview of the state-of-the-art applications of PET/CT imaging in evaluating pancreatic malignancy, comparing with conventional imaging modalities, such as contrast-enhanced CT and MRI. Current PET/MRI is also reviewed, along with brief discussion on cost-benefit analysis.

Original languageEnglish (US)
Pages (from-to)206-213
Number of pages8
JournalClinical Nuclear Medicine
Issue number3
StatePublished - Mar 13 2015



  • pancreas adenocarcinoma
  • pancreatic adenocarcinoma
  • pancreatic malignancy
  • PET/CT

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging

Cite this